C-reactive protein and efficacy of antiplatelet therapy in (intracranial) atherosclerosis

被引：3
|
作者：
Tuttolomondo, Antonino [1 ]
Pinto, Antonio [1 ]
机构：
[1] Univ Palermo, UO Med Interna Stroke Care, Dipartimento Biomed Med Interna Specialist Di Bi, I-90133 Palermo, Italy
来源：
NEUROLOGY | 2018年 / 90卷 / 06期
关键词：
ASPIRIN; BURDEN;
D O I：
10.1212/WNL.0000000000004937
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
C-reactive protein (CRP) and other inflammatory biomarkers can indicate both the severity and extent of atherosclerosis, reflecting the inflammatory nature of the disease process.(1) Atherogenesis begins with an inflammatory response to vascular injury with cells and mediators initiating the healing response and later inducing growth of atherosclerotic plaques. Inflammation then increases plaque instability, promoting rupture, fissuring, or erosionthe pathogenetic milieu of thrombosis in atherothrombotic ischemic strokes.
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [41] Antidepressant therapy and C-reactive protein levels
    O'Brien, Sinead M.
    Scott, Lucinda V.
    Dinan, Timothy G.
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 449 - 452
  • [42] No Reduction of Atherosclerosis in C-reactive Protein (CRP)-deficient Mice
    Teupser, Daniel
    Weber, Odile
    Rao, Tata Nageswara
    Sass, Kristina
    Thiery, Joachim
    Fehling, Hans Joerg
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (08) : 6272 - 6279
  • [43] Should C-Reactive Protein Be a Target of Therapy?
    Oh, Jisun
    Teoh, Hwee
    Leiter, Lawrence A.
    DIABETES CARE, 2011, 34 : S155 - S160
  • [44] Interactions of C-reactive protein with low-density lipoproteins: Implications for an active role of modified C-reactive protein in atherosclerosis
    Ji, SR
    Wu, Y
    Potempa, LA
    Qiu, Q
    Zhao, J
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (04): : 648 - 661
  • [45] Level of C-reactive protein and efficacy of therapy with aspirin in patients with ischemic heart disease
    Vasilieva, E. Yu.
    Kasyanova, O. V.
    Shpektor, A. V.
    KARDIOLOGIYA, 2006, 46 (02) : 66 - 67
  • [46] Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice
    Schwedler, SB
    Amann, K
    Wernicke, K
    Krebs, A
    Nauck, M
    Wanner, C
    Potempa, LA
    Galle, J
    CIRCULATION, 2005, 112 (07) : 1016 - 1023
  • [47] Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis
    Liu, Zhi-Zhong
    Lv, Hong
    Gao, Feng
    Liu, Gang
    Zheng, Hua-Guang
    Zhou, Ya-Li
    Wang, Ya-He
    Kang, Xi-Xiong
    CLINICA CHIMICA ACTA, 2008, 389 (1-2) : 40 - 44
  • [48] Impact of C-reactive protein on the likelihood of carotid atherosclerosis in Japanese adults
    Kawamoto, Ryuichi
    Tomita, Hitorni
    Inoue, Ai
    Ohtsuka, Nobuyuki
    Kamitani, Atsushi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (04) : 175 - 182
  • [49] Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis
    Ilhan, F
    Akbulut, H
    Karaca, I
    Godekmerdan, A
    Ilkay, E
    Bulut, V
    ACTA CARDIOLOGICA, 2005, 60 (04) : 361 - 365
  • [50] Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits
    Koike, Tomonari
    Kitajima, Shuji
    Yu, Ying
    Nishijima, Kazutoshi
    Zhang, Jifeng
    Ozaki, Yukio
    Morimoto, Masatoshi
    Watanabe, Teruo
    Bhakdi, Sucharit
    Asada, Yujiro
    Chen, Y. Eugene
    Fan, Jianglin
    CIRCULATION, 2009, 120 (21) : 2088 - U53
12345